Predicine’s Post

November is Lung Cancer Awareness Month – a time to raise awareness, support patients, and drive progress in life-saving research. Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths; and safer, more effective treatments are urgently needed to improve patient outcomes. At BiVictriX, we are dedicated to developing first-in-class, next-generation cancer therapies that deliver greater precision and safety. As part of our expanding Bi-Cygni® pipeline, we have begun work on BVX004, a programme designed to selectively target NSCLC cells while sparing healthy tissues. By leveraging our unique approach, we aim to address the high unmet medical need for effective and well tolerated therapies in NSCLC. Let’s work together to make a difference this #LungCancerAwarenessMonth: https://lnkd.in/ePvGgye9 #LungCancerAwareness #NSCLC #LungCancer #DrugDevelopment #Biotechnology

The Importance of Lung Cancer Awareness Month Lung Cancer Awareness Month is observed each November to raise awareness about lung cancer, promote screening, and support ongoing research and advocacy efforts. The 2024 theme for Lung Cancer Awareness Month is “Stronger Together: United for Lung Cancer Awareness.” This theme highlights the essential role of community support and collaboration in combating lung cancer. International Association for the Study of Lung Cancer Amy C. Moore, PhD Lung Cancer Policy Network Elliot Servais, MD, FACS Oncogene Cancer Research Eric Singhi ALK Positive Inc. The White Ribbon Project NHS Mara Antonoff Cancer Research Institute (CRI) American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) Debra Montague Shanda Blackmon Sven de Jong Shani Shilo Beth Belshaw, CMA, CPA https://lnkd.in/dYYg86eN #OncoDaily #Oncology #Cancer #Health #Medicine #HealthCare #LungCancerAwarenessMonth #LungCancer

While a lung cancer diagnosis is never easy, personalized treatment options can offer a beacon of hope.   As research continues to advance, our focus on scientific excellence and innovation is driven by our ambition to help transform the lives of patients everywhere; we’ve dedicated our world-class research capabilities to drive forward more breakthroughs for treating this disease.   On this World Lung Cancer Day, we celebrate the progress that we've made while recognizing there is still more work to be done. Together, we can pave the way for a future where lung cancer is manageable.   In case you missed it, I recently described this precision approach for non-small cell lung cancer in Endpoints News earlier this year. If you’re interested, you can read it here: https://bit.ly/3ymSs4E   #WorldLungCancerDay #LungCancerAwareness #JNJOncology #WLCD24

Today is World Lung Cancer Day. This is an annual observance designed to commemorate those who are impacted by lung cancer and raise awareness about lung cancer. Listen to Claire's story which highlights how screening led to early detection and successful treatment of her lung cancer at Regional Hospital of Scranton. Lung screening has the potential to detect lung cancer at earlier stages when it has the best chance of being treated. Commonwealth Health Imaging screens high-risk patients for lung cancer at multiple locations using low-dose CT- https://lnkd.in/dxGMEF-Q

Today, #ForesightDx recognizes World Lung Cancer Day. Lung cancer is one of the most common forms of #cancer across the globe, with non-small cell lung cancer (#NSCLC) being the most prevalent type. Identifying minimal residual disease (#MRD) from liquid biopsy is a promising method for earlier relapse detection in lung cancer. MRD can be measured using circulating tumor DNA (#ctDNA) to determine whether a patient is likely to relapse. The ability to detect even the smallest traces of ctDNA after treatment could inform decisions aimed at controlling or curing lung cancer. #ForesightDx is committed to the fight against lung cancer by enabling earlier detection of relapse and recurrence through our ultra-sensitive MRD detection platform, Foresight CLARITY™. See our recent poster on MRD detection in early-stage NSCLC here: https://t.ly/dXAiQ    Learn more about Foresight CLARITY here: https://t.ly/nAwbt    #WorldLungCancerDay #WLCD24 #UnitedForLungCancer #LungCancer #ForesightCLARITY #PrecisionMedicine #LiquidBiopsy #CancerDiagnostics #StrongerTogether

Don't forget to join us for our upcoming webinar featuring the recipients of the 2024 Lung Ambition Awards! Hosted by Dr. Paul Wheatley-Price. Hear directly from Dr. Fei Geng and Dr. Natasha Leighl as they share how their research is pushing boundaries in lung cancer care: Dr. Geng’s work on a blood-based test for earlier, cost-effective lung cancer screening could transform how we detect lung cancer and save lives. Dr. Leighl is integrating liquid biopsies into the care of patients with advanced lung cancer, helping doctors find the most effective treatments faster. These award-winning researchers are advancing lung cancer care in real, impactful ways, supported by a $50,000 grant to fuel their vital research. Catch all the details and register to learn more about their life-changing projects that could redefine the future of lung cancer care. To register: https://lnkd.in/ghTRn7wc #LungAmbitionAwards #LungCancerResearch #InnovativeCare #ScreeningSavesLives #PersonalizedTreatment #LCC #LungAmbitionAlliance #AstraZenecaCanada AstraZeneca Lung Ambition Alliance For more information on how to apply for 2025, please visit www.lccresearch.ca.

According to the American Cancer Society, lung cancer (both small cell and non-small cell) is the second most common cancer in both men and women in the United States (not counting skin cancer). The most effective way to find lung cancer at its earliest stage is with a low-dose CT lung cancer screening. A low-dose computed tomography (LDCT) screening for lung cancer is a specialized test that is used to find lung cancer before it is symptomatic and before it has spread. Talk to your doctor to see if a LDCT is right for you! https://lnkd.in/gjusQFJ2

METASTATIC CANCER Metastatic cancer refers to cancer that has spread beyond the point of origin to other distant areas of the body. Metastasis is a word used to describe the spread of cancer. Unlike normal cells, cancer cells have the ability to grow outside of the place in your body where. they originated. When this happens, it's called metastatic cancer, advanced cancer or Stage IV cancer. The most common sites for cancers to metastasize include the lungs, liver, bones and brain. Other places include the adrenal gland, lymph nodes, skin and other organs. Some people will have minimal or no symptoms of metastatic cancer. In most cases, metastatic cancer is not curable. However, treatment can slow growth and ease many of the associated symptoms. #snsinstitutions #snsdesignthinking #snsdesignthinkers

🌟 Commemorating Lung Cancer Awareness Month at ClinActis 🌟   This November, as we recognize Lung Cancer Awareness Month, we reflect on the progress made since the first major breakthroughs in lung cancer treatment, from chemotherapy and radiation to today’s targeted therapies and immunotherapies. These advancements have extended survival rates and improved quality of life for countless individuals worldwide.   Despite these strides, lung cancer remains one of the most prevalent and deadly cancers, especially in the Asia-Pacific region where rates continue to rise. At ClinActis, we’re committed to advancing clinical research that explores innovative treatments, from precision medicine to new immunotherapies. Together, we’re working toward a future where lung cancer is more preventable, treatable, and ultimately curable.   #LungCancerAwarenessMonth #ClinicalResearch #ClinActis #LungCancerAwareness #APAC

August 1st is Lung Cancer Awareness Day. Did you know that 1 in 16 people will be diagnosed with lung cancer in their lifetime and that 5-year survival is 10 times higher for people diagnosed with localized versus metastatic disease? Early detection is a critical tool to help combat the devastating impact of this disease. At Mercy, we are proud to be developing the Mercy Halo Lung Cancer assay; a high performance, blood-based test designed to detect lung cancer at its earliest stages, when it’s most treatable.   To learn more about our research on the early detection of lung cancer please visit www.mercybio.com To learn more about current methods for lung cancer screening, visit https://lnkd.in/dZM9D6SY #worldlungcancerday #lungcancer #lungcancerawareness #cancerresearch #mercybio #earlycancerdetection